BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 22407164)

  • 1. A NMR and computational study of Smac mimics targeting both the BIR2 and BIR3 domains in XIAP protein.
    Potenza D; Belvisi L; Vasile F; Moroni E; Cossu F; Seneci P
    Org Biomol Chem; 2012 Apr; 10(16):3278-87. PubMed ID: 22407164
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design and characterization of bivalent Smac-based peptides as antagonists of XIAP and development and validation of a fluorescence polarization assay for XIAP containing both BIR2 and BIR3 domains.
    Nikolovska-Coleska Z; Meagher JL; Jiang S; Kawamoto SA; Gao W; Yi H; Qin D; Roller PP; Stuckey JA; Wang S
    Anal Biochem; 2008 Mar; 374(1):87-98. PubMed ID: 18023397
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A mechanistic insight into SMAC peptide interference with XIAP-Bir2 inhibition of executioner caspases.
    Abhari BA; Davoodi J
    J Mol Biol; 2008 Sep; 381(3):645-54. PubMed ID: 18619610
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural basis for bivalent Smac-mimetics recognition in the IAP protein family.
    Cossu F; Milani M; Mastrangelo E; Vachette P; Servida F; Lecis D; Canevari G; Delia D; Drago C; Rizzo V; Manzoni L; Seneci P; Scolastico C; Bolognesi M
    J Mol Biol; 2009 Sep; 392(3):630-44. PubMed ID: 19393243
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of a heterodimeric Smac-based peptide that features sequences specific to both the BIR2 and BIR3 domains of the X-linked inhibitor of apoptosis protein.
    Speer KF; Cosimini CL; Splan KE
    Biopolymers; 2012; 98(2):122-30. PubMed ID: 22020922
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting the X-linked inhibitor of apoptosis protein through 4-substituted azabicyclo[5.3.0]alkane smac mimetics. Structure, activity, and recognition principles.
    Mastrangelo E; Cossu F; Milani M; Sorrentino G; Lecis D; Delia D; Manzoni L; Drago C; Seneci P; Scolastico C; Rizzo V; Bolognesi M
    J Mol Biol; 2008 Dec; 384(3):673-89. PubMed ID: 18851976
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Requirement of both the second and third BIR domains for the relief of X-linked inhibitor of apoptosis protein (XIAP)-mediated caspase inhibition by Smac.
    Huang Y; Rich RL; Myszka DG; Wu H
    J Biol Chem; 2003 Dec; 278(49):49517-22. PubMed ID: 14512414
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biochemical basis for enhanced binding of peptide dimers to X-linked inhibitor of apoptosis protein.
    Splan KE; Allen JE; McLendon GL
    Biochemistry; 2007 Oct; 46(42):11938-44. PubMed ID: 17910418
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Theoretical studies on the interactions of XIAP-BIR3 domain with bicyclic and tricyclic core monovalent Smac mimetics.
    Ling B; Dong L; Zhang R; Wang Z; Liu Y; Liu C
    J Mol Graph Model; 2010 Nov; 29(3):354-62. PubMed ID: 20980180
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design, synthesis, and characterization of a potent, nonpeptide, cell-permeable, bivalent Smac mimetic that concurrently targets both the BIR2 and BIR3 domains in XIAP.
    Sun H; Nikolovska-Coleska Z; Lu J; Meagher JL; Yang CY; Qiu S; Tomita Y; Ueda Y; Jiang S; Krajewski K; Roller PP; Stuckey JA; Wang S
    J Am Chem Soc; 2007 Dec; 129(49):15279-94. PubMed ID: 17999504
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dimeric Smac mimetics/IAP inhibitors as in vivo-active pro-apoptotic agents. Part II: Structural and biological characterization.
    Lecis D; Mastrangelo E; Belvisi L; Bolognesi M; Civera M; Cossu F; De Cesare M; Delia D; Drago C; Manenti G; Manzoni L; Milani M; Moroni E; Perego P; Potenza D; Rizzo V; Scavullo C; Scolastico C; Servida F; Vasile F; Seneci P
    Bioorg Med Chem; 2012 Nov; 20(22):6709-23. PubMed ID: 23062821
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Conformational selection, dynamic restriction and the hydrophobic effect coupled to stabilization of the BIR3 domain of the human X-linked inhibitor of apoptosis protein by the tetrapeptide AVPI.
    de Souza TL; Sanches D; Gonçalves RB; da RochaPita SS; Pascutti PG; Bianconi ML; de Almeida FC; Silva JL; de Oliveira AC
    Biophys Chem; 2010 Nov; 152(1-3):99-108. PubMed ID: 20843595
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interaction of a cyclic, bivalent smac mimetic with the x-linked inhibitor of apoptosis protein.
    Nikolovska-Coleska Z; Meagher JL; Jiang S; Yang CY; Qiu S; Roller PP; Stuckey JA; Wang S
    Biochemistry; 2008 Sep; 47(37):9811-24. PubMed ID: 18717598
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The structure of the BIR3 domain of cIAP1 in complex with the N-terminal peptides of SMAC and caspase-9.
    Kulathila R; Vash B; Sage D; Cornell-Kennon S; Wright K; Koehn J; Stams T; Clark K; Price A
    Acta Crystallogr D Biol Crystallogr; 2009 Jan; 65(Pt 1):58-66. PubMed ID: 19153467
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design, synthesis, and biological activity of a potent Smac mimetic that sensitizes cancer cells to apoptosis by antagonizing IAPs.
    Zobel K; Wang L; Varfolomeev E; Franklin MC; Elliott LO; Wallweber HJ; Okawa DC; Flygare JA; Vucic D; Fairbrother WJ; Deshayes K
    ACS Chem Biol; 2006 Sep; 1(8):525-33. PubMed ID: 17168540
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural insight into inhibitor of apoptosis proteins recognition by a potent divalent smac-mimetic.
    Cossu F; Milani M; Vachette P; Malvezzi F; Grassi S; Lecis D; Delia D; Drago C; Seneci P; Bolognesi M; Mastrangelo E
    PLoS One; 2012; 7(11):e49527. PubMed ID: 23166698
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Copper-binding properties of the BIR2 and BIR3 domains of the X-linked inhibitor of apoptosis protein.
    Liang Y; Ewing PM; Laursen WJ; Tripp VT; Singh S; Splan KE
    J Inorg Biochem; 2014 Nov; 140():104-10. PubMed ID: 25105866
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular basis of SMAC-XIAP binding and the effect of electrostatic polarization.
    Tian S; Ji C; Zhang JZH
    J Biomol Struct Dyn; 2021 Feb; 39(2):743-752. PubMed ID: 31914860
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In silico discovery of acylated flavonol monorhamnosides from Eriobotrya japonica as natural, small-molecular weight inhibitors of XIAP BIR3.
    Pfisterer PH; Shen C; Nikolovska-Coleska Z; Schyschka L; Schuster D; Rudy A; Wolber G; Vollmar AM; Rollinger JM; Stuppner H
    Bioorg Med Chem; 2011 Jan; 19(2):1002-9. PubMed ID: 21087868
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure-activity based study of the Smac-binding pocket within the BIR3 domain of XIAP.
    Wist AD; Gu L; Riedl SJ; Shi Y; McLendon GL
    Bioorg Med Chem; 2007 Apr; 15(8):2935-43. PubMed ID: 17336535
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.